Rizatriptan Benzoate undergo hepatic first pass metabolism. Aim of present research work is to improve bioavailability by formulating in-situ nasal gel. Formulation was developed to decrease the mucociliary authorization by using mucoadhesive polymer in gel, thus rising the contact time with nasal mucosa and humanizing the absorption of drug. Gels were primed by cold technique process and evaluate by Appearance, Viscosity, Gelation Temperature, Permeation Studies, Drug Content, Gel strength etc.. The gelation temperature of all studied gel formulations were found in range. Drug release was initiated in between 68.8-94.7% with Kpeppas best fit model. pH of gel was in the rang and drug content was found between 92-99.89 %. Gel strength was found in range of 20-55 sec.
INTRODUCTION
The bioavailability of drugs from nasal formulations depends on the physicochemical properties of drug and formulation that work together to yield optimal drug delivery across the membrane. There are certain criteria that the drug should satisfy to be distributed optimally from the nasal formulation. These are molecular weight, lipophilicity, solubility, partition coefficient and pKa.
Extent of the absorption of the drug depends on molecular weight particularly for hydrophilic compounds. The absorption of molecules less than 300 Da may not be influenced by their physicochemical properties. Nasal route is suitable for efficient delivery of the drugs up to 1000 Da. Absorption reduces significantly if the molecular weight is greater than 1000
Da except with the use of penetration enhancers. Lipophilic drugs have been found to be relatively more permeable across the nasal epithelium. Drug solubility is a major factor in determining absorption of drug through biological membranes. As nasal secretions are more watery in nature, a drug should have appropriate aqueous solubility for increased dissolution 1, 2, 3 .
The conventional drug delivery systems like solutions, suspensions and ointments, emulsions are no longer sufficient to fulfill the present day requirements of providing a constant rate delivery and prolonged time.
One of the main reasons for that is poor residence time of drug at the site of action, which results into poor bioavailability. To overcome this problems gel is the dosage form to improve the residence time and increased the bioavailability Gels are defined as a substantially dilute cross-linked system, which exhibits no flow when in the steady-state. Gel state exists between solid and liquid phase. It has properties ranging from soft and weak to hard and tough.
In situ is a Latin word which means in position. In situ gel formation is a liquid formulation that generates a solid or semisolid depot after administration and shift to a gel phase when exposed to physiological conditions. This new concept of producing a gel in situ was introduced for the first time in the early 1980s. Both natural and synthetic polymers can be used for the production of in situ gels 5. 6 .
Carbomer is high molecular weight, cross linked polyacrylic acid derivative with a strong mucoadhesive property. Carbopol being a pH dependant polymer is present in solution form at acidic pH but at alkaline pH forms a low viscosity gel. Carbopol polymers have very good water sorption property 7 . They swell in water upto 1000 times their original volume and 10 times their original diameter to form a gel when exposed to a pH environment above 4.0-6.0 because the pKa of these polymers is 6.0 ± 0.5.
Rizatriptan benzoate is completely absorbed following oral administration. The mean oral absolute bioavailability of the Rizatriptan benzoate tablet is about 45% and means peak plasma concentration (Cmax) reaches in approximately 1-1.5 hours (Tmax). The presence of a migraine headache did not appear to affect the absorption or pharmacokinetics of Rizatriptan benzoate. Food has no significant effect on the bioavailability of Rizatriptan benzoate but delays the time to reach peak concentration by an hour. In clinical trials, Rizatriptan benzoate was administered without regard to food. The plasma half-life of Rizatriptan benzoate in males and females averages 2-3 hours [8] [9] [10] [11] .
Present study is to achieve brain targeted drug delivery of rizatriptan benzoate for patients suffering from migraine. It is a general study that tries to cover a noseto-brain pathway for drug rizatriptan benzoate, intranasal delivery, which significantly increases brain accumulation of rizatriptan benzoate and could be an effective alternative to parentral and oral formulations. The nasal ruote will be able to provide longer residence properties and hence better bioavailability of the drug. Formulation in the nasal cavity exhibited prolonged drug release characteristics with almost negligible toxic effects to the nasal mucosa. The ease of administration coupled with its ability to provide sustained release could probably result in less frequent administration, thus enhancing patient compliance.
MATERIALS AND METHOD
Rizatriptan Benzoate was obtained from M/s Torrent Pharmaceuticals Pvt. Ltd., Other chemicals and instruments were used analytical grade.
METHODS

Preparation of gels
Nasal gels were prepared using bioadhesive polymers at its optimum concentrations as determined by viscometric studies. The materials were dissolved in a measured volume of nasal solution. The insides were sonicated using Pci Ultrasonic cleaner for 10 min and stirred in a magnetic stirrer for 15 min. The whole substance was sealed and stored in the refrigerator overnight to allow complete swelling. An aliquot amount of Rizatriptan Benzoate was added and stirred again for 15 min. The prepared gel was sonicated to ensure the complete removal of air bubbles. Similarly gels were prepared using different enhancers. 
Evaluation of Gels Appearance
The developed formulations were inspected visually for clarity in sol and gel form.
pH of the gels
The pH of the formulations was gritty by bring the electrode of the pH meter in contact with the surface of the formulation and allowing it to equilibrate for 1min 12, 13 .
Gelation Studies
The in situ gel forming solution and the artificial nasal fluid were mixed and the gelation was observed by visual examination. Gelation studies were carried out according to (Balasubhramanian J. et al 2003) 14 in different pH Buffers (pH5.0, 6.0, 6.6, 7.4) and was assessed by visual examination. Gelation temperature and gel melting was assessed by a modified process 15 
Content uniformity
Formulations were tested for content uniformity. Bottles containing the formulation were properly shaken for 2.3 min. The formulation, 1.0 ml was transferred into a 100-ml volumetric flask and 50 ml of simulated nasal fluid was added. The formed gel was completely crushed with the help of a glass rod, followed by vigorous shaking until the formed gel got completely dispersed to give a clear solution. The volume was adjusted to 100 ml with simulated tear fluid. The solution was filtered through a 0.45-mm filter membrane and the drug concentration was determined with a UV-Visible spectrophotometer at 280 nm 16, 17 .
Determination of Mucoadhesive Strength
Mucoadhesive Strengths of gel was determined by using the modified method reported by Choi et al 18 . Nasal mucosal tissues, obtained from the local slaughterhouse, were carefully removed from the nasal cavity of goat and mounted on glass surface using adhesive tape while another mucosal section was fixed in inverted position to the cylinder. 50mg of gel was placed on mucosal surface. The glass mounted mucosal surface with gel formulation and mucosal surface attached to cylinder were held in contact with each other for 2min to ensure intimate contact between them. In second pan, the weights were kept rising until two mucosa get detached from each other. The nasal mucosa was changed for each measurement
Viscosity Measurement
The viscosity measurements were carried out by using Brookfield DV Pro-II model with spindle No.62.The instrument was equipped with the temperature control unit and the sample were equilibrated for 10 min before the measurement. The viscocity was measured against increasing shear rate. Measurement was taken at 4 0 c and 34 0 c respectively 19 .
In-vitro Release Studies
The drug release of the Rizatriptan Benzoate in situ gel was measured using Franz diffusion cell. Assembly was set and the temperature was maintained at 37±0.5°C, then 2 ml of nasal in situ gel of Rizatriptan Benzoate in was applied in the donor compartment, which was separated by the receptor compartment with the cellophane membrane. Three ml aliquots of samples were withdrawn at regular time intervals and replaced with an equal volume of phosphate buffer as fresh receptor medium. The samples were appropriately diluted with Phosphate buffer and analyzed spectrophotometrically (Double beam UV-visible spectrophotometer) at 280 nm 20 .
Drug release kinetics and mechanism:
In order to understand the kinetic and mechanism of drug release, the result of in vitro drug release study of nasal in situ gels were fitted with various mathematical models. Based on the R2-value or n-value, the bestfitted model was selected 21, 22 .
Drug content estimation
Each formulation (1 ml) was taken in a 100 ml volumetric flask diluted with distilled water and shaken to dissolve the drug. The solution was filtered through whatmann filter paper and 1ml of filtered solution was further diluted to 100 ml with distilled water. Drug content was estimated spectrophotometrically by measuring the absorbance of the above solution at 280 nm 23, 24 .
RESULTS AND DISCUSSION
Mucoadhesive Polymer Formulations
Mucoadhesive dosage forms have gained and still gaining, considerable interest as a means of providing intimate contact and prolonging the residence time of a dosage form intended for nasal and ocular administration
It generally accepted that process involves three steps; wetting and swelling of the polymer to permit intimate contact with biological tissue, interpenetration of bioadhesive polymer chains with mucin molecules leading to entanglement and formation of weak chemical bonds between entangled chains, the mechanisms by which mucoadhesion bonds form are not completely clear. There are five theories of adhesion have been developed to explain the properties of wide range of materials including glues, adhesives and paint. Clarity of all the formulations was found to be satisfactory.
Evaluations of Gels
Appearance
pH of mucoadhesive nasal gels
The pH of the formulations was found to be satisfactory and was in the range of 4.5-5.5.
Gelation Temperature
It was previously proved that pluronics undergo thermal gelation or sol-gel transition at a temperature of about 25 to 37°C. Below the transition temperature Pluronic solutions allow a comfortable and precise delivery in the nasal cavity where thermogelation occurs. Immediate gelling increases residence time and enhances bioavailability of drug. The gelation temperature of all batches is shown in table 3. In Pluronic gels, gelation studies in 20-24 %( w/w) concentration showed that gelation temperature decreases with increase in gel melting temperature as Pluronic concentration increases. Gelation of PF-127 was found dependent on aqueous solubility of the polymer. was observed due to the availability of carboxyl group. Carbopol has very high percentage of (58%-68%) of carboxyl group that undergoes hydrogen bonding with sugar residues in oligosaccharide chain in mucus membrane, resulting in strengthened network between polymer and mucus membrane. The stronger the Mucoadhesive force is, the more it can prevent the gelled solution coming out of the nose. respectively. This indicates that process employed to prepare gels in this study was capable of producing gels with uniform drug content and minimal gel variability.
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Drug Release
Diffusion studies were carrying out using franz diffusion cell, F5 showed the persistent drug release. F3 showed drug release 79.76% at 8hrs. Concentration of HPMC raise leads to decrease the drug release. Poloxamer concentration distress on drug release. Ex vivo permeation carried out by using nasal mucosa of goat and permeation profile shown in the above figure.
Stability studies
All the formulation showed good stability at 27 °C/ 60 % RH. There were no significant changes in visual appearance and clarity; pH remained constant for entire stability period; drug content did not deviate by than 2% indicating that the drug is stable in the in situ gel formulations and also there was no significant variation in the in vitro release studies at the end of 30 day period. A formulation intended for a nasal administration, if prepared as a solution should not show precipitation of the drug present in it for long periods of storage. This is achieved when formulations were stored at normal room temperatures not exceeding 32 °C. The formulation when stored under refrigerated conditions showed settling of the polymer and also the viscosity of the formulation increased. The formulations when stored at 45 °C/ 75 % RH, the formulations remained as a gel for long duration. 
